JPWO2022071601A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022071601A5
JPWO2022071601A5 JP2022554159A JP2022554159A JPWO2022071601A5 JP WO2022071601 A5 JPWO2022071601 A5 JP WO2022071601A5 JP 2022554159 A JP2022554159 A JP 2022554159A JP 2022554159 A JP2022554159 A JP 2022554159A JP WO2022071601 A5 JPWO2022071601 A5 JP WO2022071601A5
Authority
JP
Japan
Prior art keywords
protein
level
patient
marker
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022554159A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022071601A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/036525 external-priority patent/WO2022071601A1/ja
Publication of JPWO2022071601A1 publication Critical patent/JPWO2022071601A1/ja
Publication of JPWO2022071601A5 publication Critical patent/JPWO2022071601A5/ja
Pending legal-status Critical Current

Links

JP2022554159A 2020-10-02 2021-10-01 Pending JPWO2022071601A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020168107 2020-10-02
PCT/JP2021/036525 WO2022071601A1 (ja) 2020-10-02 2021-10-01 血中エクソソームのタンパク質マーカーを利用したcovid-19重症化予測方法

Publications (2)

Publication Number Publication Date
JPWO2022071601A1 JPWO2022071601A1 (https=) 2022-04-07
JPWO2022071601A5 true JPWO2022071601A5 (https=) 2024-10-09

Family

ID=80951770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022554159A Pending JPWO2022071601A1 (https=) 2020-10-02 2021-10-01

Country Status (5)

Country Link
US (1) US20240263234A1 (https=)
EP (1) EP4223887A4 (https=)
JP (1) JPWO2022071601A1 (https=)
CN (1) CN114556105A (https=)
WO (1) WO2022071601A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023007809A1 (ja) * 2021-07-29 2023-02-02 国立大学法人東北大学 コロナウイルス感染症の重症化リスクの評価方法、およびコロナウイルス感染症の重症化リスク評価キット
CN115097147B (zh) * 2022-08-23 2022-11-25 细胞生态海河实验室 预测奥密克戎复阳风险的生物标志物及代谢、蛋白、联合模型
KR20250107848A (ko) 2022-11-07 2025-07-14 아이에스엠 가부시키가이샤 코트머단백질 복합체 서브유닛 베타2에 대한 항체
WO2024181522A1 (ja) * 2023-02-28 2024-09-06 国立大学法人大阪大学 Covid-19を検査する方法
CN117467598B (zh) * 2023-12-28 2024-05-10 健颐生物科技发展(山东)有限公司 肝细胞源pcsk9外泌体的制备方法
WO2025170060A1 (ja) * 2024-02-08 2025-08-14 学校法人慈恵大学 急性肺障害治療薬
CN119177277B (zh) * 2024-10-08 2025-05-27 北京医院 与结肠癌细胞对吉西他滨耐药性相关的circ86591的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2697653B1 (en) * 2011-04-15 2016-03-30 Children's Medical Center Corporation Diagnostic markers and therapeutic targets of kawasaki disease
CN111366728A (zh) * 2020-03-27 2020-07-03 重庆探生科技有限公司 一种用于检测新型冠状病毒SARS-CoV-2的免疫层析试剂盒

Similar Documents

Publication Publication Date Title
JPWO2022071601A5 (https=)
TWI708058B (zh) 阿茲海默症及其他神經退化性疾病之生物標記及診斷方法
US12205677B2 (en) System and method for analysis of biological data
WO2022071601A1 (ja) 血中エクソソームのタンパク質マーカーを利用したcovid-19重症化予測方法
US20120178637A1 (en) Biomarkers and methods for detecting alzheimer's disease
JP2015514227A (ja) 結核バイオマーカーおよびその使用
WO2021251504A1 (ja) 血中rnaを利用したcovid-19重症化予測方法
WO2011014349A1 (en) Serum markers predicting clinical response to anti-tnfalpha antibodies in patients with psoriatic arthritis
CN116287220B (zh) 用于快速诊断川崎病的分子生物标志物和分析方法
CN110702917B (zh) 血清淀粉样蛋白p在制备抑郁症诊断治疗相关产品的用途
EP3052939B1 (en) Kidney disease biomarker
WO2012033999A2 (en) Biomarkers for predicting kidney and glomerular pathologies
WO2015164616A1 (en) Biomarkers for detection of tuberculosis
CN116287207B (zh) 生物标志物在诊断心血管相关疾病中的应用
KR101788404B1 (ko) 활동성 루푸스신염 검출용 바이오마커 및 그 용도
CN113416777A (zh) 与糖尿病肾病发生发展相关的生物标志物及其应用
JP6252949B2 (ja) 統合失調症マーカーセット及びその利用
CN116449025B (zh) 尿液蛋白作为原发性胆汁性胆管炎诊断标志物的应用
KR101859812B1 (ko) 간암 화학 색전술 치료 예후 예측을 위한 바이오마커 및 그 용도
CN109997043A (zh) 护理点测定法
TWI921387B (zh) 利用血中胞外體之蛋白質標記之covid-19重症化預測方法
WO2007148720A1 (ja) ネフローゼ症候群の疾患関連たんぱく質およびその使用
CN114729936A (zh) 在尿液样本中诊断结核的方法
CN117647645B (zh) Lbp、atf6、m-csfr联用在制备诊断自身免疫性肝病产品中的应用及试剂盒
CN119162301A (zh) 用于狼疮肾炎诊断的生物标志物及其应用